The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease.
about
Functional imaging in Huntington's disease.Seeking brain biomarkers for preventive therapy in Huntington disease.Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease.New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease.Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease.Positron emission tomography imaging of transplant function.Decreased Metabolism in the Cerebral Cortex in Early-Stage Huntington's Disease: A Possible Biomarker of Disease Progression?Milestones in neuroimaging.Huntington's disease: update and review of neuropsychiatric aspects.Huntington disease: new insights into the relationship between CAG expansion and disease.A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia.Social system responses to Huntington disease.Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease.SPECT, CT and MRI in a Turkish family with Huntington's disease.Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease.Evidence of presymptomatic cognitive decline in Huntington's disease.The FDG/PET methodology for early detection of disease onset: a statistical model.CAG repeat number governs the development rate of pathology in Huntington's disease.Striatal hypometabolism in premanifest and manifest Huntington's disease patients.Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease.Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease.Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology.Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year.Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography.Striatal Glucose Metabolism and Pattern of Cerebral Regional Interactions in Choreic Disorders
P2860
Q33403110-D6BBFDF9-EECF-45A4-822E-BE446A5D3954Q33606063-9C182535-A42E-40BC-BFEB-9E45DD6AD0FDQ33649261-B582568D-52E7-44E7-868C-A4F1DBF31A62Q35243890-136156C1-C951-4407-BFC5-4A5EBCEAC075Q35254212-6BEFE3B4-2384-439D-8E18-AB2C5A4EE54EQ36045301-43DF4560-BC91-4C15-A11A-F392BFAF3B05Q36045402-F9309824-617D-4107-832C-6177307B3CA6Q36528726-0945882B-A772-4DCE-A9E8-EF150BCF7114Q37882576-AA78C3A6-CE08-4C67-A5C9-A9E7F4EA578EQ40612866-F2D2896C-1F28-474B-992A-43E5FFCE6658Q41170305-FDD87B83-4B42-4F35-BAB8-5B97B780F0CEQ41175762-493FAEAF-FBD3-4F52-8F7D-C51ED2F3DD9CQ43782764-037FB630-39BB-4DEF-84F6-827787484473Q44306361-6A0AFD65-01A3-4149-914D-DAE6682DBED3Q45290030-EFD1505F-EB8C-421F-A455-746BE985F0B1Q45290224-97DE60CE-62A3-45DD-8FA0-DDEE4A229696Q45291624-02E91B0C-8C8F-47B7-8DCA-2FAACDD5655FQ45291667-22D3A06F-9EB0-44AF-9585-FD47960648B2Q45292923-AA94DDA9-2AB8-4A05-B7D2-E99BFDA63D04Q45294278-49E4B2D8-5742-4C66-B71F-3D6ED010AB6BQ45295893-591C2936-07E5-44AB-BE9E-7C93393AB824Q45298929-9BF860C1-6D7C-4806-B3AA-6D2FFC3EC01EQ45300446-9D951EC4-9A6F-4A31-BA57-E4430BAD01A0Q45305215-4048738A-8086-488D-9D02-26F1089D8AA1Q45306639-E4A8AA1E-E7F3-46BD-9AB4-DF0B36E51881Q45307360-6F893793-AB69-48FE-8145-7DE42257BBBBQ57834630-4B5BB335-CD6E-40EC-B35D-33094C8BE3DF
P2860
The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
The combined use of positron e ...... ction of Huntington's disease.
@en
The combined use of positron e ...... ction of Huntington's disease.
@nl
type
label
The combined use of positron e ...... ction of Huntington's disease.
@en
The combined use of positron e ...... ction of Huntington's disease.
@nl
prefLabel
The combined use of positron e ...... ction of Huntington's disease.
@en
The combined use of positron e ...... ction of Huntington's disease.
@nl
P2093
P356
P1433
P1476
The combined use of positron e ...... ction of Huntington's disease.
@en
P2093
P304
P356
10.1212/WNL.37.9.1441
P407
P577
1987-09-01T00:00:00Z